HomePharma

Pharma

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Life Sciences Times - April 30, 2026

Pharma

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Life Sciences Times - April 30, 2026

Pharma

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

Life Sciences Times - April 30, 2026

Pharma

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Life Sciences Times - April 29, 2026

Pharma

FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer

Life Sciences Times - April 28, 2026

Pharma

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Life Sciences Times - February 23, 2021 0

Pharma

Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients

Life Sciences Times - February 22, 2021 0

Pharma

Xlife Sciences AG: Antiviral drug candidate for SARS-CoV-2

Life Sciences Times - February 17, 2021 0

Pharma

M6P Therapeutics Presents Promising Preclinical Data in Lysosomal Storage Disorders at the 17th Annual WORLDSymposium™ 2021

Life Sciences Times - February 11, 2021 0

Pharma

Drug Topics® Announces Partnership with inPharmacyJobs

Life Sciences Times - February 11, 2021 0

Pharma

New Zealand approves 1st Covid-19 vaccine

Life Sciences Times - February 10, 2021 0

Pharma

Global Anti-inflammatory Drugs Market to Surpass US$ 142,223.4 Million by 2027, Says Coherent Market Insights

Life Sciences Times - February 8, 2021 0

Pharma

COVAXX’s COVID-19 Vaccine, UB-612, Induced Neutralizing Antibodies in 100% of Participants During Phase 1 Clinical Trial

Life Sciences Times - February 8, 2021 0

Pharma

AstraZeneca’s anti-diabetic drug gets nod for kidney disease in India

Life Sciences Times - February 8, 2021 0

Pharma

Reverie Labs Raises $25 Million Series A Round

Life Sciences Times - February 5, 2021 0

Pharma

MYLUNG Study Launches, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

Life Sciences Times - February 4, 2021 0

Pharma

AstraZeneca says vaccine 76% effective for 90 days after single dose

Life Sciences Times - February 3, 2021 0

1...868788...91 Page 87 of 91

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

April 30, 2026

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

April 30, 2026

Moleculent Raises $20 Million to Expand Functional Profiling Platform

April 30, 2026

Komodo Health Names Paul Thomas Chief Financial Officer

April 30, 2026

Pharma

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer

Most Read

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

Moleculent Raises $20 Million to Expand Functional Profiling Platform

Komodo Health Names Paul Thomas Chief Financial Officer

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Moleculent Raises $20 Million to Expand Functional Profiling Platform

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

LightForce Launches Patient-Specific 3D-Printed Metal Braces

POPULAR CATEGORY

ABOUT US

FOLLOW US